The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
Retinal diseases, which can lead to significant vision loss, are complex conditions involving various cellular and molecular mechanisms. The interleukin-6 (IL-6) family, particularly Oncostatin M (OSM), has garnered attention for their roles in retinal inflammation, angiogenesis, and neuroprotection...
Saved in:
Main Authors: | Mori Tommaso, Nagaraj Nareshkumar Ragavachetty, Surico Pier Luigi, Zhou Wenjing, Parmar Uday Pratap Singh, D’Esposito Fabiana, Gagliano Caterina, Musa Mutali, Zeppieri Marco |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2024-12-01
|
Series: | Open Life Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1515/biol-2022-1023 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncostatin M [OSM] protein immuno-expression in oral squamous cell carcinoma – A prospective study
by: Sunil Prakash, et al.
Published: (2024-06-01) -
Naringenin, a Food Bioactive Compound, Reduces Oncostatin M Through Blockade of PI3K/Akt/NF-κB Signal Pathway in Neutrophil-like Differentiated HL-60 Cells
by: Na-Ra Han, et al.
Published: (2025-01-01) -
Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA): A Targeted Antioxidant Strategy to Counter Oxidative Stress in Retinopathy
by: Marco Zeppieri, et al.
Published: (2024-12-01) -
Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1
by: Yinghao Guo, et al.
Published: (2025-01-01) -
β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis
by: Yijia Zhang, et al.
Published: (2025-02-01)